C43.12

Clinical Causes: Excessive exposure to ultraviolet (UV) radiation from the sun or tanning beds. Having a fair complexion, freckles, or light-colored eyes, which can increase susceptibility. A personal or family history of skin cancers or melanoma. Presence of atypical moles or moles with irregular features. Repeated or chronic skin injury or inflammation in the eyelid area. Immune system suppression, such as in organ transplant recipients or those on immunosuppressive therapy.

Key Symptoms: A new or changing pigmented lesion on the eyelid, especially if irregular in shape, color, or size. A sore that does not heal or a lesion that bleeds easily. Dark or pigmented streaks or patches on the eyelid. Itching, tenderness, or swelling in the affected area. Changes in the appearance of existing moles near the eyelid. Presence of a lump or thickening in the eyelid or canthus.

Diagnosis Path: Diagnosis typically involves a thorough eye and skin examination by a healthcare professional. The dermatologist or ophthalmologist will assess the lesion’s appearance and may perform a dermoscopic examination. Confirmatory diagnosis is achieved through a skin biopsy, where a sample of tissue from the lesion is examined microscopically for malignant cells. Additional imaging studies, such as ultrasound or MRI, might be used to assess the extent of local invasion and potential spread to nearby structures or lymph nodes. Sentinel lymph node biopsy may be considered if there is concern about metastasis.

Treatment Protocols: Treatment options depend on the size, depth, and spread of the melanoma. Common approaches include: - Surgical excision: Complete removal of the tumor with clear margins to ensure all cancerous cells are eliminated. - Mohs micrographic surgery: A precise surgical method that removes the tumor layer by layer, examining each layer microscopically until no cancer cells remain, preserving healthy tissue. - Lymph node dissection: If metastatic spread to lymph nodes is suspected or confirmed. - Adjuvant therapies: Such as immunotherapy or targeted therapy for advanced or metastatic melanoma. - Close follow-up: Regular examinations to monitor for recurrence or new lesions. The choice of treatment is made by a multidisciplinary team tailored to individual cases and disease stage.